Dimitrios Zardavas Selected Research

Dimitrios Zardavas Research Topics

Disease

31	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2012
17	Neoplasms (Cancer) 02/2023 - 11/2012
5	Triple Negative Breast Neoplasms 08/2022 - 01/2016
3	Cardiotoxicity 01/2020 - 08/2014
2	Diarrhea 01/2020 - 07/2017
2	Heart Failure 01/2020 - 01/2019
2	Pathologic Complete Response 01/2015 - 11/2012
1	Carcinoma (Carcinomatosis) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 02/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Hypertensive Encephalopathy 01/2019
1	Infections 01/2019
1	Mastodynia 01/2019
1	Disease Progression 01/2016
1	Hypersensitivity (Allergy) 01/2016
1	Neutropenia 01/2016
1	Lymphoma (Lymphomas) 01/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011

Drug/Important Bio-Agent (IBA)

13	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2013
7	human ERBB2 proteinIBA 08/2022 - 11/2012
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2014
5	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2012
4	Hormones (Hormone)IBA 01/2019 - 09/2014
3	Phenobarbital (Luminal)FDA Link 01/2019 - 11/2012
3	AnthracyclinesIBA 04/2018 - 08/2014
3	Estrogen ReceptorsIBA 01/2018 - 11/2012
2	NivolumabIBA 02/2023 - 01/2021
2	atezolizumabIBA 09/2021 - 01/2020
2	pertuzumabIBA 01/2020 - 07/2017
2	taxaneIBA 01/2020 - 11/2017
2	Lapatinib (GW572016)FDA Link 04/2018 - 01/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 01/2016
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2017 - 11/2012
2	MTOR InhibitorsIBA 08/2014 - 11/2012
1	Immunoconjugates (Immunoconjugate)IBA 06/2022
1	B7-H1 AntigenIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	AntidiarrhealsIBA 01/2020
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2019
1	Letrozole (Femara)FDA LinkGeneric 01/2019
1	Trinitrotoluene (TNT)IBA 04/2018
1	pro-brain natriuretic peptide (1-76)IBA 04/2018
1	Cyclin D1IBA 01/2018
1	abemaciclibIBA 12/2017
1	ribociclibIBA 12/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2017
1	palbociclibIBA 12/2017
1	Epidermal Growth Factor (EGF)IBA 11/2017
1	NVP-BKM120IBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 06/2017
1	Androgen Receptors (Androgen Receptor)IBA 06/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2017
1	TroponinIBA 03/2017
1	GadoliniumIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	TOR Serine-Threonine KinasesIBA 11/2012
1	temsirolimus FDA Link 01/2011

Therapy/Procedure

18	Therapeutics 02/2023 - 11/2012
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2012
3	Neoadjuvant Therapy 01/2019 - 01/2015
1	Adjuvant Chemotherapy 07/2017
1	Molecular Targeted Therapy 12/2016
1	Premedication 01/2016
1	Segmental Mastectomy (Lumpectomy) 01/2015
1	Precision Medicine 01/2015
1	Stem Cell Transplantation 01/2013